![]() HIQA is the statutory organisation in Ireland with a responsibility to carry out national health technology assessments (HTAs) and to develop guidelines for the conduct of HTAs across our healthcare system.Marty Whelan, Head of Communications and Stakeholder Engagement, Health Information and Quality Authority, 086 2447 623, to the Editor: The HTA report has been submitted to the Health Service Executive ( HSE) for consideration. From the limited data that is available, IPC appears to be a potentially beneficial treatment for people at risk of amputation who are not candidates for revascularisation, but until reliable evidence is generated in the context of well designed research studies, this treatment remains unproven.” ![]() Additional well designed studies are required to reliably demonstrate the clinical effectiveness of IPC in these patients.ĭr Máirín Ryan, Director of Health Technology Assessment in HIQA, said: “Although some promising results have been seen to date, there is a lack of high quality, reliable evidence to support the widespread adoption of this technology. No serious adverse events related to the use of IPC were reported. However, all identified studies involved small numbers of patients and had significant methodological limitations. Available results from lower quality studies suggest that the intervention may be associated with improved limb salvage rates, wound healing and pain management. ![]() The Authority’s assessment found that there is a lack of high quality studies examining the clinical effectiveness of IPC in this patient group. The Authority conducted a systematic review and critical appraisal of the evidence on the use of IPC treatment in this population. ![]() IPC has been proposed as a treatment that can be used in addition to best medical management and is designed to increase blood flow in the lower limbs to relieve pain, promote wound healing and decrease the risk of amputation.IPC devices consist of an inflatable cuff, or series of cuffs, that wrap around the affected leg and apply controlled cyclical compression for a set duration. The Health Information and Quality Authority has published the results of a health technology assessment ( HTA) of intermittent pneumatic compression ( IPC) for people with severe peripheral arterial disease who are not candidates for revascularisation via angioplasty or surgical intervention. Acute and Community Healthcare Services. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |